Similar articles

• Lowering homocysteine with B vitamins in patients with coronary artery disease.

  Ntaios G, Savopoulos C, Hatzitolios A. Ntaios G, et al. JAMA. 2008 Dec 24;300(24):2852-3; author reply 2853-4. doi: 10.1001/jama.2008.836. JAMA. 2008. PMID: 19109109 No abstract available.
• Lowering homocysteine with B vitamins in patients with coronary artery disease.

  Scholl J. Scholl J. JAMA. 2008 Dec 24;300(24):2853; author reply 2853-4. doi: 10.1001/jama.2008.837. JAMA. 2008. PMID: 19109111 No abstract available.
• Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.

  Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygård O. Ebbing M, et al. JAMA. 2008 Aug 20;300(7):795-804. doi: 10.1001/jama.300.7.795. JAMA. 2008. PMID: 18714059 Clinical Trial.
• [Homocysteine and coronary artery disease].

  Aro A. Aro A. Duodecim. 2003;119(12):1131-5. Duodecim. 2003. PMID: 12868359 Review. Finnish. No abstract available.
• The controversial role of B-vitamins in cardiovascular risk: An update.

  Ntaios G, Savopoulos C, Grekas D, Hatzitolios A. Ntaios G, et al. Arch Cardiovasc Dis. 2009 Dec;102(12):847-54. doi: 10.1016/j.acvd.2009.07.002. Arch Cardiovasc Dis. 2009. PMID: 19963194 Review.